Author Topic: Mayzent (siponimod, BAF312) for active SPMS, RRMS  (Read 525 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8588
  • MS diagnosed 1980
  • Location: Pacific Northwest
Novartis prices Mayzent at $88K/year
« Reply #15 on: March 28, 2019, 02:21:45 pm »
More on this in SeekingAlpha, March 27, 2019:


https://seekingalpha.com/news/3446145-novartis-prices-ms-med-mayzent-88k-year



Someone on another site stated that Mayzent (siponimod) is the generic form of Gilenya (fingolimod). This article (see link) states:


Quote
Siponimod, a synthetic derivative of fingolimod, is designed for an improved safety profile, including less deleterious effects on heart rate and nerves.


Is a "synthetic derivative" the same as a generic form?
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
74 Views
Last post April 01, 2019, 04:00:21 pm
by agate
0 Replies
39 Views
Last post May 06, 2019, 09:17:34 pm
by agate
1 Replies
66 Views
Last post October 02, 2019, 06:23:25 am
by agate
0 Replies
38 Views
Last post October 31, 2019, 08:49:09 am
by agate
0 Replies
18 Views
Last post January 29, 2020, 09:35:32 pm
by agate